Barbara Yanni - 10 May 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Maurice Zauderer, Attorney-in-Fact for Barbara Yanni
Issuer symbol
VCNX
Transactions as of
10 May 2024
Net transactions value
$0
Form type
4
Filing time
14 May 2024, 16:33:55 UTC
Previous filing
20 Jun 2023
Next filing
14 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +10,108 $0.000000 10,108 10 May 2024 Common Stock 10,108 $5.75 Direct F7
holding VCNX Stock Option (Right to Buy) 30 10 May 2024 Common Stock 30 $2856.00 Direct F1
holding VCNX Stock Option (Right to Buy) 36 10 May 2024 Common Stock 36 $1633.80 Direct F2
holding VCNX Stock Option (Right to Buy) 74 10 May 2024 Common Stock 74 $829.50 Direct F3
holding VCNX Stock Option (Right to Buy) 136 10 May 2024 Common Stock 136 $451.50 Direct F4
holding VCNX Stock Option (Right to Buy) 253 10 May 2024 Common Stock 253 $235.20 Direct F5
holding VCNX Stock Option (Right to Buy) 684 10 May 2024 Common Stock 684 $86.10 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable in full as of the date of this report.
F2 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F3 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F4 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F5 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F6 This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
F7 This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first.

Remarks:

All figures in this Form 4 reflect the Issuer's 1-for-15 reverse stock split effected on September 25, 2023 and 1-for-14 reverse stock split effected on February 19, 2024.